A Somatropin Counterfeit Challenging the European Pharmacopoeia Monograph

Author： Charton E.   Wierer M.   Spieser J.M.   van Dorsselaer A.   Rautmann G.  

Publisher： Pharmaceutical Press

ISSN： 1460-8081

Source： Pharmacy and Pharmacology Communications, Vol.5, Iss.1, 1999-01, pp. : 61-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The European Pharmacopoeia monographs for heparin preparations have been revised

By  

Reactions Weekly, Vol. 1, Iss. 1212, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

A case study of preservation of semi-solid preparations using the European Pharmacopoeia test: comparative efficacy of antimicrobial agents in zinc gelatin

By Favet J.   Chappuis M.-L.   Doelker E.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 52, Iss. 2, 2001-09 ,pp. : 255-259

Elsevier

Access to resources Recommend Favorite

Serono's somatropin [`Serostim'] has again failed to win approval from the European Commission's CPMP

By  

Inpharma, Vol. 1, Iss. 1405, 2003-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

FDA reviews safety of somatropin

By  

Reactions Weekly, Vol. 1, Iss. 1334, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Somatropin a success in treating HARS

By  

Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite